In short. Stinging, redness, contact allergy and a dermatosis are four different problems filed under one phrase, and which one you have decides everything that follows.

Key points

  • No test reports sensitive skin.
  • What can be tested is what sits underneath it: a patch test identifies a delayed allergy to a specific substance.
  • Everything else is established by a history, an examination and a subtraction trial.

Four people use the same two words about their faces. One stings when anything is applied, because the outer layer has been stripped. One has rosacea, in which flushing is the condition. One is reacting to a preservative in a product used for two years. One stings with nothing visible on the skin.

What the phrase is doing

Sensitive skin describes symptoms rather than a disease. It says the skin reacts more than expected, and it does not say why. That is what a symptom is, but it means the phrase cannot be treated: what can be treated is whatever produces the reaction, and there are four candidates.

The four, in the order they are usually found

A barrier left less able to hold. The outer layer keeps water in and irritants out. Stripped by harsh cleansers, acids or peels, both jobs fail together: the surface feels tight and things that never used to sting begin to sting. This is the commonest kind, and the kind most often made worse by trying harder.

A dermatosis. Rosacea, eczema, contact dermatitis and seborrheic dermatitis all present with burning, redness or flaking, and patients describe all four as sensitive skin. Each has features of its own, and each answers to a treatment a barrier cream is not.

A contact allergy. A delayed reaction to one ingredient spreads beyond where the product was applied and continues to worsen while it is still used. It is usually one product rather than everything, and it is found by patch testing or by subtraction.

A nerve sensitivity. Some people sting and burn with nothing visible on the skin, reproducibly, in response to a few substances. Nothing is inflamed. Escalating treatment does not help, because there is nothing on the surface to treat.

A description, not a diagnosis

No test reports sensitive skin. What can be tested is what sits underneath it: a patch test identifies a delayed allergy to a specific substance. Everything else is established by a history, an examination and a subtraction trial.

Why naming it changes the plan

A barrier problem is treated by taking things away and waiting. A dermatosis is treated by naming it, with a routine supporting that treatment. An allergy is treated by identifying the substance and avoiding it. Attempt the wrong one and the skin gets worse, which the person reads as evidence that their skin is unusually difficult.

Signs the label has not been made specific

  • The reactivity has been present for years without ever being given a name.
  • Products have been changed repeatedly, none of them stopped on its own.
  • The skin now reacts to things it tolerated a year ago, and the routine keeps growing.

Which conditions have to be excluded before a routine is blamed is the subject of why a dermatosis comes first, and the surface underneath is described in what a damaged barrier actually is. How the kinds are separated is in how sensitive skin is assessed.

Related reading

Frequently asked questions

How can I tell whether my reactivity is the barrier or something else?

The pattern and the timing are the most useful things you can observe on your own. Barrier reactivity is general, it gets worse with washing, and it improves when the routine is shortened. A rash confined to where a product touches, redness across the centre of the face with flushing, or stinging with nothing visible at all point elsewhere, and each of those has its own plan.

Can two of these problems be present at the same time?

Yes, and it is common. Someone with rosacea can also have a barrier that no longer holds water well, and someone with eczema can develop a contact allergy to a treatment they are using for it. Treating one and not the other leaves the skin uncomfortable, and the second problem is often found only when the first has been controlled and something still does not fit.

If I have reacted to several products, does that prove my skin is the problem?

It proves only that several products contained something your skin does not tolerate, which is not the same thing. Several unrelated products can share a preservative, a fragrance mix or a surfactant family, and a run of reactions across them is a reason to read ingredient lists carefully rather than a reason to conclude that nothing will ever suit you.

Risks & Limitations

  • This is managed rather than cured. Reactive skin settles while the routine that settled it is kept up, and a routine replaced with a more ambitious one usually brings the reactivity back.
  • A topical steroid used on the face for longer than a short prescribed course causes redness and thinning of the skin itself, which is why it is prescribed with a duration attached.
  • A light or laser treatment delivered to a barrier that has not been stable for weeks can leave skin more reactive than it was, and the result cannot be interpreted afterwards.
  • No product and no clinician can promise that a routine will settle your skin, and any statement that promises it should be treated with suspicion.

When to Seek Care

  • Blistering, peeling or a rash spreading quickly over the face or body — seek prompt medical care.
  • Swelling of the lips, eyelids or tongue, or a rash with fever and feeling unwell — seek emergency care.
  • An eye that is painful, gritty or light-sensitive, or any change in vision alongside facial redness.
  • Skin that is eroded, oozing, crusted or painful rather than merely reactive.

References & Further Reading

  • American Academy of Dermatology (AAD) — patient guidance on this condition
  • International League of Dermatological Societies (ILDS) — global standards of care
  • National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
  • Cochrane Library — systematic reviews

Medically reviewed by Yongbo Jia, MD (贾勇波), Deputy Director & Head of Dermatology. Last reviewed: 19 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.